150019-56-0

Basic information

• Product Name: 8-(benzo[d][1,3]dioxol-5-yl)-1,4-dioxaspiro[4.5]decan-8-ol
• Synonyms: 8-(benzo[d][1,3]dioxol-5-yl)-1,4-dioxaspiro[4.5]decan-8-ol;8-(1,3-benzodioxol-5-yl)-1,4-dioxaspiro[4.5]decan-8-ol
• CAS NO: 150019-56-0
• Molecular Formula: C₁₅H₁₈O₅
• Molecular Weight: 278.30042
• Mol File: 150019-56-0.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 439.4±45.0 °C(Predicted)
• Appearance: /
• Density: 1.36±0.1 g/cm3(Predicted)
• PKA: 14.12±0.20(Predicted)
• CAS DataBase Reference: 8-(benzo[d][1,3]dioxol-5-yl)-1,4-dioxaspiro[4.5]decan-8-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 8-(benzo[d][1,3]dioxol-5-yl)-1,4-dioxaspiro[4.5]decan-8-ol(150019-56-0)
• EPA Substance Registry System: 8-(benzo[d][1,3]dioxol-5-yl)-1,4-dioxaspiro[4.5]decan-8-ol(150019-56-0)

Safety Data

• Hazardous Substances Data: 150019-56-0(Hazardous Substances Data)

Usage

General Description

8-(benzo[d][1,3]dioxol-5-yl)-1,4-dioxaspiro[4.5]decan-8-ol is an organic compound with a complex chemical structure. It contains a benzodioxole ring and a dioxaspirodecanol ring, both of which are important functional groups in organic chemistry. The compound is known for its spirocyclic structure, which is a bicyclic compound where one ring shares two carbon atoms with another. 8-(benzo[d][1,3]dioxol-5-yl)-1,4-dioxaspiro[4.5]decan-8-ol has potential applications in the pharmaceutical industry, particularly in the development of new drugs and bioactive molecules. Its unique structure and functional groups make it an interesting target for organic chemists and medicinal chemists studying its properties and potential uses.

Upstream product

• 4746-97-8 cyclohexanedione monoethylene ketal 
• 2635-13-4 1,2-(methylenedioxy)-4-bromobenzene 
• 17680-04-5 (3,4-methylenedioxy)phenylmagnesium bromide 
• 274-09-9 Methylenedioxybenzene 

Downstream Products

• 150019-57-1 4-(1,3-benzodioxol-5-yl)-4-hydroxycyclohexanone 
• 150019-59-3 1-benzo[1,3]dioxol-5-yl-4-piperazin-1-yl-cyclohexanol 
• 150019-58-2 Cis phenylmethyl-4-[4-(1,3-benzodioxol-5-yl)-4-hydroxy-1-cyclohexyl]-1-piperazine carboxylate 

Relevant articles and documents

NOVEL 5 or 8-SUBSTITUTED IMIDAZO [1, 5-a] PYRIDINES AS SELECTIVE INHIBITORS OF INDOLEAMINE AND/OR TRYPTOPHANE 2, 3-DIOXYGENASES

Disclosed herein are 5 or 8-substituted imidazo [1, 5-a] pyridines and pharmaceutical compositions comprising at least one such 5 or 8-substituted imidazo [1, 5-a] pyridines, processes for the preparation thereof, and the use thereof in therapy. Disclosed herein are certain 5 or 8-substituted imidazo [1, 5-a] pyridines that can be useful for inhibiting indoleamine 2, 3-dioxygenase and/or tryptophane 2, 3-dioxygenase and for treating diseases or disorders mediated thereby.

4-AZETIDINYL-1-PHENYL-CYCLOHEXANE ANTAGONISTS OF CCR2

The present invention comprises compounds of Formula (I): wherein: X, R1, R2, R3, and R4 are as defined in the specification. The invention also comprises a method of preventing, treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is type II diabetes, obesity and asthma. The invention also comprises a method of inhibiting CCR2 activity in a mammal by administration of a therapeutically effective amount of at least one compound of Formula (I).

Piperazinyl-cyclohexanes and cyclohexenes

Novel non-dopaminergic antiischemic compounds have Formula I: wherein R=R1 and is independently H, C1-4 alky C1-4 alkoxy, C1-4 trihaloalkyl or halogen, or R and R1 may be taken together to form an -O(CH2)mO- (m=1 or 2); X=a 3-indolyl, phenyl, naphthalenyl or 2-benzothiazolyl residue; n=0, 1, 2 or 3; R2=R3 and is independently H or C1-4 alkyl; and R4=phenyl, 2-thienyl, 2-quinolinyl, 4-pyridinyl or substituted phenyl.